|Mr. Rubino Di Girolamo||Chairman of Management Board & CEO||N/A||N/A||1962|
|Mr. Marek Hahn||Member of Management Board & CFO||236k||N/A||1974|
aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany and the United States. The company offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. It also provides bone graft substitutes, including Artosal, a fully synthetic osteoconductive bone substitute; Cerabone, a ceramic bone replacement material; PerOssal, a synthetic biodegradable osteostimulating and osteoconductive bone replacement material; Calcifix, a calcium phosphate cement; and ReproBone, an injectable granulated paste, as well as GlassBONE, a bioactive glass. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
aap Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.